Global Cell Therapy Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 14.8% during the forecast period.
Global Cell Therapy Market Overview:
Cell therapy is the introduction of viable cells into a patient’s body in order to grow, replace or repair damaged tissue in order to treat a disease. For example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Global Cell Therapy Market Dynamics:
Technological advancements in the medical field and rise in number of clinical studies are the primary factors driving the market growth.
The rising incidence of chronic and infectious diseases is the vital factor escalating the market growth. Also, the rise in adoption of human cells for cell therapeutics research, technological advancements in the field of cell therapy, and the increase in adoption of regenerative medicine contribute to the market growth. The surge in the number of regulations to promote stem cell therapy and increase in funds for research in developing countries are expected to offer lucrative opportunities for the market in the future. Apart from this, the demand for precision medicine in the field of oncology where a patient receives personalized treatment creates potential opportunities for the cell therapy market growth. However, certain factors like the increased cost of cell-based research and the rising dearth of skilled professionals may hamper the market growth.
The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing RD activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Global Cell Therapy Market Segment Analysis:
The global Cell Therapy Market is segmented on the basis of Therapy Type, Cell type, Application and End-Users.
Based on Therapy Type, the autologous therapy segment dominated the market in 2020 and is expected to maintain dominance throughout the forecast period. This can be attributed to several advantages associated with autologous transplants such as easy availability, no need to identify an HLA-matched donor, lower risk of life-threatening complications, no risk of GVHD, and no necessity of immunosuppressive therapy. In addition, autologous therapies are affordable when compared to allogeneic therapies which can be further attributed to segment growth.
Based on Cell Type, the stem cell segment contributed the largest share of the global cell therapy market in 2019 and is expected to retain its dominance during forecast years. The segment growth is accounted due to an increase in awareness regarding the storage of stem cells and the growing number of stem cell banks in the developing nations have a positive impact on market growth.
Global Cell Therapy Market
To know about the Research Methodology :- Request Free Sample Report
Global Cell Therapy Market Regional Insights:
Global Cell Therapy Market by Regional
North America held dominant market share in 2020 and is expected to continue the dominance throughout the forecast period.
North America market is anticipated to hold prominent market share owing to the increasing incidence of target diseases like cancer and rising demand for its advanced treatment other than chemotherapy. Also, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region augment the market growth in the region.
Asia Pacific is expected to witness lucrative growth during forecast period.
Asia-Pacific exhibits high potential for growth in the market owing to a high patient pool due to large population in many countries. Moreover, developing countries such as India and China are expected to experience growth, owing to surge in healthcare infrastructure, increase in affordability, and rise in awareness related to cell therapy.
The report also helps in understanding Global Cell Therapy Market dynamics, structure by analyzing the market segments and project the Global Cell Therapy Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Cell Therapy Market make the report investor’s guide.
In August 2019, Bayer AG, a Germany-based pharmaceutical and life sciences company, acquired BlueRock Therapeutics, an engineered cell therapy company, for $1 billion. Through this transaction, Bayer AG will acquire complete BlueRock Therapeutics' CELL+GENE platform, including a broad intellectual property portfolio and associated technology platform including proprietary iPSC technology, gene engineering, and cell differentiation capabilities.
According to the report by the UK’s Cell and Gene Therapy (CGT) Catapult – a center of excellence for the cell and gene therapy industry, states that despite the tremendous impact of COVID-19 on many industries, the number of advanced therapy medicinal product (ATMP) clinical trials continued to grow in 2020. Covid-19 has made biopharmaceutical reformers across the world come forward in response to the pandemic which, in turn, has impacted the global cell therapy market positively.
Global Cell Therapy Market Scope: Inquire before buying
Global Cell Therapy Market by Scope
Global Cell Therapy Market, by Region:
• North America
• South America
Global Cell Therapy Market, Key Players:
• Kolon TissueGene, Inc.
• Anterogen Co., Ltd.
• JCR Pharmaceuticals Co., Ltd.
• Castle Creek Biosciences, Inc.
• The Future of Biotechnology, MEDIPOST
• Osiris Therapeutics, Inc.
• PHARMICELL Co., Ltd
• Tameika Cell Technologies, Inc.
• Cells for Cells
• NuVasive, Inc.
• Vericel Corporation
• Celgene Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Danaher Corporation
• Becton, Dickinson and Company
• Lonza Group
• Sartorius AG
• Terumo BCT
• Fresenius Medical Care AG Co. KGaA